John J. Sperzel III, associated with T2 Biosystems, Inc. [TTOO], executed a transaction on February 24, 2024, involving the acquisition of 67 shares of common stock. This transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Sperzel's direct holdings in T2 Biosystems have reached a total of 400 shares. The transaction price and total value of the shares were not disclosed in the announcement.

John J. Sperzel III, associated with T2 Biosystems, Inc. [TTOO], executed a transaction on February 24, 2024, involving the acquisition of 67 shares of common stock. This transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Sperzel's direct holdings in T2 Biosystems have reached a total of 400 shares. The transaction price and total value of the shares were not disclosed in the announcement.